Jarogniew Luszczki Selected Research

Pentylenetetrazole (Metrazol)

1/2020	Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain.
3/2002	Effects of tamoxifen, mifepristone and cyproterone on the electroconvulsive threshold and pentetrazole-induced convulsions in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jarogniew Luszczki Research Topics

Disease

3	Neoplasms (Cancer) 06/2022 - 05/2021
2	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2021
2	Epilepsy (Aura) 01/2020 - 03/2002
1	Triple Negative Breast Neoplasms 06/2022
1	Neoplasm Metastasis (Metastasis) 06/2022
1	Seizures (Absence Seizure) 03/2002

Drug/Important Bio-Agent (IBA)

2	Paclitaxel (Taxol)FDA LinkGeneric 06/2022 - 01/2022
2	SirtuinsIBA 06/2022 - 01/2022
2	Histone Deacetylase InhibitorsIBA 01/2022 - 05/2021
2	Pentylenetetrazole (Metrazol)IBA 01/2020 - 03/2002
1	cambinolIBA 06/2022
1	Estrogen ReceptorsIBA 06/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2022
1	human ERBB2 proteinIBA 06/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Sirtuin 2IBA 01/2022
1	CyproteroneIBA 03/2002
1	Estrogen Receptor Modulators (Antiestrogen)IBA 03/2002
1	Androgen Antagonists (Antiandrogens)IBA 03/2002
1	Tamoxifen FDA LinkGeneric 03/2002
1	Mifepristone (RU 486)FDA Link 03/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2022
1	Therapeutics 06/2022